# FDA Inspection 1090255 - Biotest Pharmaceuticals Corporation - March 28, 2019

Source: https://www.keypedia.com/records/fda_inspections/biotest-pharmaceuticals-corporation/2298b219-462d-49df-918b-44af4b7b10b3
Source feed: FDA_Inspections

> FDA Inspection 1090255 for Biotest Pharmaceuticals Corporation on March 28, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1090255
- Company Name: Biotest Pharmaceuticals Corporation
- Inspection Date: 2019-03-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1044391 - 2017-12-20](https://www.keypedia.com/records/fda_inspections/biotest-pharmaceuticals-corporation/80f334dc-e7fb-4c79-89d9-b1badd6041da)

Company: https://www.keypedia.com/companies/biotest-pharmaceuticals-corporation/6c75890c-985c-4235-9662-6287ae85930c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d